EVANSTON, Ill.--(BUSINESS WIRE)--Feb. 24, 2006--Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: STATEMENT OF NORTHFIELD LABORATORIES REGARDING ITS PIVOTAL PHASE III TRIAL--Northfield Laboratories (NASDAQ: NFLD) released the following statement today in response to news reports that Senator Charles Grassley (R-Iowa) has raised questions about the Northfield trauma trial research protocol:
